Sartorius Stedim (Germany) Price Prediction
| 56S1 Stock | EUR 183.30 1.10 0.60% |
Oversold Vs Overbought
48
Oversold | Overbought |
Using Sartorius Stedim hype-based prediction, you can estimate the value of Sartorius Stedim Biotech from the perspective of Sartorius Stedim response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Sartorius Stedim to buy its stock at a price that has no basis in reality. In that case, they are not buying Sartorius because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Sartorius Stedim after-hype prediction price | EUR 183.3 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sartorius |
Sartorius Stedim After-Hype Price Prediction Density Analysis
As far as predicting the price of Sartorius Stedim at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sartorius Stedim or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sartorius Stedim, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sartorius Stedim Estimiated After-Hype Price Volatility
In the context of predicting Sartorius Stedim's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sartorius Stedim's historical news coverage. Sartorius Stedim's after-hype downside and upside margins for the prediction period are 179.92 and 186.68, respectively. We have considered Sartorius Stedim's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sartorius Stedim is very steady at this time. Analysis and calculation of next after-hype price of Sartorius Stedim Biotech is based on 3 months time horizon.
Sartorius Stedim Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Sartorius Stedim is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sartorius Stedim backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sartorius Stedim, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.15 | 3.38 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
183.30 | 183.30 | 0.00 |
|
Sartorius Stedim Hype Timeline
Sartorius Stedim Biotech is presently traded for 183.30on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Sartorius is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is presently at 0.15%. %. The volatility of related hype on Sartorius Stedim is about 0.0%, with the expected price after the next announcement by competition of 183.30. About 74.0% of the company shares are owned by insiders or employees . The company has Price/Earnings (P/E) ratio of 110.44. Sartorius Stedim Biotech recorded earning per share (EPS) of 9.32. The entity last dividend was issued on the 30th of March 2023. The firm had 6:1 split on the 6th of May 2016. Assuming the 90 days trading horizon the next projected press release will be in 5 to 10 days. Check out Sartorius Stedim Basic Forecasting Models to cross-verify your projections.Sartorius Stedim Related Hype Analysis
Having access to credible news sources related to Sartorius Stedim's direct competition is more important than ever and may enhance your ability to predict Sartorius Stedim's future price movements. Getting to know how Sartorius Stedim's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sartorius Stedim may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| COP | CompuGroup Medical SE | 0.00 | 0 per month | 1.65 | 0.18 | 6.62 | (2.46) | 32.53 | |
| 4QVA | Siamgas And Petrochemicals | 0.00 | 0 per month | 2.18 | 0 | 5.88 | (5.56) | 11.44 | |
| K41 | SCANDMEDICAL SOLDK 040 | 0.00 | 0 per month | 0.00 | (0.09) | 3.85 | (3.70) | 15.63 | |
| DPD3 | IMAGIN MEDICAL INC | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 8HH | Avanos Medical | 0.00 | 0 per month | 0.00 | (0.14) | 3.55 | (3.76) | 20.85 | |
| H1Q | China BlueChemical | 0.00 | 0 per month | 2.50 | 0.08 | 8.33 | (4.76) | 16.70 | |
| QUC | Quaker Chemical | 0.00 | 0 per month | 0.00 | (0.08) | 3.42 | (2.67) | 15.36 |
Sartorius Stedim Additional Predictive Modules
Most predictive techniques to examine Sartorius price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sartorius using various technical indicators. When you analyze Sartorius charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Sartorius Stedim Predictive Indicators
The successful prediction of Sartorius Stedim stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sartorius Stedim Biotech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sartorius Stedim based on analysis of Sartorius Stedim hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sartorius Stedim's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sartorius Stedim's related companies.
Story Coverage note for Sartorius Stedim
The number of cover stories for Sartorius Stedim depends on current market conditions and Sartorius Stedim's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sartorius Stedim is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sartorius Stedim's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Sartorius Stedim Short Properties
Sartorius Stedim's future price predictability will typically decrease when Sartorius Stedim's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sartorius Stedim Biotech often depends not only on the future outlook of the potential Sartorius Stedim's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sartorius Stedim's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 92.2 M |
Complementary Tools for Sartorius Stock analysis
When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |